Ibere Pharmaceuticals (IBER) Stock Price, News & Analysis

Company Overview

Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.

Key Stats

• Today's Range: $10.18 to $10.18
• 50-Day Range: $10.15 to $10.21
• 52-Week Range: $9.74 to $10.75
• Volume: 44,499 shs
• Average Volume: 110,000 shs
• Market Capitalization: $175.61 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 7/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Holding & other investment offices
• Sub-Industry: N/A
• Current Symbol: NYSE:IBER
• CIK: 1835205
• Web: www.iberepharma.com
• Phone: 267-765-3222
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $1.56 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -83.01%
• Return on Assets: 4.47%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.24
• Quick Ratio: 0.24

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: $0.09 per share
• Price / Cash Flow: 112.42
• Book Value: ($0.63) per share
• Price / Book: -16.16

Miscellaneous

• Outstanding Shares: 17,250,000
• Free Float: 13,800,000
• Market Cap: $175.61 million
• Optionable: Not Optionable
• Beta: N/A